Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vision blurred, Visual impairment, Visual perseveration, Visual snow syndrome, Vitreous floaters
Clinical narrative: Blood vessels in eyes; Eye floaters; Photosensitivity; Visual snow syndrome; Left sided headache; Tingling on left side of fingers; Left side of foot; Eye flashes; Blurry vision; Poor vision; Nausea; Loud tinnitus; Palinopsia; Halos and starburst around lights; Seeing colors in a dark room; Flickering lights when opening eyes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26-year-old male patient received BNT162b2 (BNT162B2), on 18Jan2022 as dose 1, single (Batch/Lot number: unknown) at the age of 26 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Covid-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: VITAMIN C [ASCORBIC ACID]; FISH OIL. Past drug history included: Ceftin, reaction(s): "Allergy_Ceftin". The following information was reported: EYE HAEMORRHAGE (medically significant) with onset 20Jan2022, outcome "not recovered", described as "Blood vessels in eyes"; VISION BLURRED (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Blurry vision"; OCULAR DISCOMFORT (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Eye flashes"; VITREOUS FLOATERS (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Eye floaters"; PHOTOPSIA (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Flickering lights when opening eyes"; VISUAL IMPAIRMENT (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Halos and starburst around lights"; LIMB DISCOMFORT (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Left side of foot"; HEADACHE (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Left sided headache"; TINNITUS (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Loud tinnitus"; NAUSEA (non-serious) with onset 20Jan2022, outcome "not recovered"; VISUAL PERSEVERATION (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Palinopsia"; PHOTOSENSITIVITY REACTION (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Photosensitivity"; VISUAL IMPAIRMENT (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Poor vision"; SYNAESTHESIA (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Seeing colors in a dark room"; PARAESTHESIA (non-serious) with onset 20Jan2022, outcome "not recovered", described as "Tingling on left side of fingers"; VISUAL SNOW SYNDROME (non-serious) with onset 20Jan2022, outcome "not recovered". The events "blood vessels in eyes", "eye floaters", "photosensitivity", "visual snow syndrome", "left sided headache", "tingling on left side of fingers", "left side of foot", "eye flashes", "blurry vision", "poor vision", "nausea", "loud tinnitus", "palinopsia", "halos and starburst around lights", "seeing colors in a dark room" and "flickering lights when opening eyes" required physician office visit. Therapeutic measures were not taken as a result of eye haemorrhage, vitreous floaters, photosensitivity reaction, visual snow syndrome, headache, paraesthesia, limb discomfort, ocular discomfort, vision blurred, visual impairment, nausea, tinnitus, visual perseveration, visual impairment, synaesthesia, photopsia. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination: Dietary Supplement: Vitamin C, Fish Oil. Patient was patient diagnosed with COVID-19 Prior to vaccination. Patient did not test for COVID-19 Since the vaccination. Device Date: 24Apr2022  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.